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Interferon (IFN) production by human peripheral lymphocytes stimulated with M.
pneumoniae was investigated. The hydrogen peroxide released from M. pneumoniae was
responsible for the induction of IFN from lymphocytes, since horseradish peroxidase inhibited
the IFN production and abrogated the activity of IFN production in the supernatant of M.
pneumoniae. The antiserum neutralizing IFNa and IFN,3 failed to neutralize partially in-
terferon produced by lymphocytes. Treatment either with pH 2.0 or antiserum neutralizing
human IFNy resulted in a partial reduction ofinterferon. These results indicate that interferon
produced by human lymphocytes stimulated with M. pneumoniae includes both types of IFNy
and IFNI3.
INTRODUCTION
Increasing evidence indicates that the production of different types of interferon
(IFN) such as a, ,B, andy are induced in immunocompetent cells as well as in other
animal cells by various stimulators including virus, bacteria, synthetic polyamines,
low-molecular synthetics, and mitogens [1]. Among human mycoplasmas, M.
pneumoniae is considered a pathogen which causes upper respiratory infections and
pneumonia in man. Also, M. pneumoniae produces hydrogen peroxide as a final
metabolite ofglucose which lyses erythrocytes ofvarious animals [2,3]. On the other
hand, there have been several reports that mycoplasmas [4,5,6,7,8] and
mycoplasmatales virus [9] induced IFN production when inoculated in leukocytes
and tissue-culture cells.
As we recently found that hydrogen peroxide induced IFN by peripheral lym-
phocytes, the present study was designed to determine whether the hydrogen perox-
ide produced by M. pneumoniae could induce IFN byM. pneumoniae-infected lym-
phocytes.
MATERIALS AND METHODS
Mycoplasma
Mycoplasma pneumoniae FH strain was supplied by Prof. M. Nakamura,
Kurume University, Kurume, Japan. The microorganisms were cultured in PPLO liq-
uid medium, without thallium acetate, at 37°C. After four days' cultivation, the
culture was harvested and frozen at -80°C until use.
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Peripheral blood mononuclear cells were prepared from the heparinized
peripheral venous blood of healthy adults by centrifugation over a Ficoll-Isopaque
gradient [10]. The cells, designated peripheral blood mononuclear cells, were washed
three times with Hanks' balanced salt solution (G-HBSS, Nissui Seiyaku Co., Japan)
with 0.1 percent gelatin (Difco Laboratories, Detroit, MI). The residual erythrocytes
were lysed by the addition of 1 ml cold Tris-0.83 percent NH4Cl solution to the cell
pellets in the tubes, followed by an incubation at 37°C for five minutes; the cells
were then washed three times and resuspended in culture medium.
Purification of T Cells
Nonphagocytic nonadherent and T cell-enriched mononuclear cells were obtained
from the peripheral blood treated with iron phagocytosis followed by Ficoll-
Isopaque gradient centrifugation and nylon filtration as described [11]. The car-
bonyl iron-treated peripheral blood was centrifuged over a Ficoll-Isopaque gradient
to separate mononuclear cells from the blood. Theseparated mononuclear cells were
washed two times with G-HBSS and resuspended with culture mediumcontaining 10
percent fetal calf serum (FCS, Grand Island Biological Co., Gibco, Grand Island,
NY). The cell suspensions were then applied on a nylon wool column in the plastic
syringe to remove adherent cells (B cells) [11]. These combined methods of iron
phagocytosis and nylon filtration generally yield lymphocyte preparations contain-
ing less then 0.1 percent of either monocytes or B cells as determined by E rosette
and myeloperoxidase staining [12].
Purification ofB Cells
Mononuclear cells obtained from the carbonyl iron-treated peripheral blood by
Ficoll-Isopaque density gradient centrifugatons were added in a ratio of 1:50 to
sheep red blood cells (SRBC) treated with neuraminidase (from Vibrio cholerae,
Behring-Werke AG, Marburg, West Germany) as described [11]. The mixture was
incubated at 37°C for 10 minutes, spun down at 160 g for five minutes and then kept
at0°C for 45 minutes. After incubation, the mixture was resuspended very gently by
pipetting. The cell suspensions were overlaid on Ficoll-Isopaque gradient and cen-
trifuged at 150 g for five minutes and subsequently at 600 g for 10 minutes. The
bound cells in the interface of the gradient were used as B cells. This procedure
generallyyielded lymphocyte preparations which contained more than 85-95 percent
of B cells, the others being T cells.
Determination ofthe Number ofMycoplasmas
Ten microliters ofeach dilution were plated out on agar media in triplicate and in-
cubated for six days at 37°C in a humidified chamber. The number of colony-
forming units per milliliter was then determined by counting colonies on the agar
plates.
IFNAssay
The antiviral activity was assayed by using 50 percent plaque reduction technique
in WISH cells with vesicular stomatitis virus (VSV) as a challenge virus [13]. For the
assay, 0.1 ml of the test materials diluted to a ratio of 1:2 was added in triplicate to
monolayers of WISH cells in a 96-well plate (Nunc) and the plate was incubated at
37°C for 24 hours. After removing the sample solution, 30-40 plaque-forming units
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(PFU) of VSV were added to each well and the plates were incubated at 37°C for 90
minutes to allow virus adsorption. After removing the unadsorbed virus, 0.1 ml of
the medium containing 0.4 percent methyl cellulose (M281, Fisher Scientific Co.,
Fair Lawn, NJ) was added to each well. After incubation at 37°C for 24 hours, the
medium was removed and the cells were stained with 1 percent crystal violet in
ethanol to reveal virus plaques. IFN titers were expressed as reciprocal values ofthe
dilution which reduced the number of virus plaques by 50 percent. A laboratory
standard IFN preparation was included with each assay.
Culture Condition
Culture for cells was carried out in round-bottom microtest plates (Nunc Co.
Ltd., Denmark). Each well contained 20 x 104 cells in0.2 ml ofRPMI 1640 (Gibco)
fortified with 10 percent FCS and 2 mM L-glutamine. Cultures were then incubated
in a humidified atmosphere of 5 percent CO2 in air at 37°C. The supernatants were
harvested and stocked at - 80°C, until their antiviral activities were assayed.
Typing ofIFN
Both antisera neutralizing human IFNct and IFN'y were purchased from In-
terferon Sciences Inc., New Brunswick, NJ. Antiserum to IFNcx was a sheep an-
tiserum to interferon produced in human leukocytes induced by Sendai virus. An-
tiserum to IFN3 was a rabbit antiserum to interferon produced in human fibroblasts
induced by Sendai virus. Antiserum to IFN-y was a rabbit antiserum against purified
IFN,y from plant lectin-stimulated human lymphocyte culture supernatants. IFNa
and IFN^y used as controls were also purchased form Interferon Sciences Inc. For
neutralization, 0.2 ml oftest interferon preparations at 100 units/ml was mixed with
an equal volume of antiserum or culture medium as control. After one hour of in-
cubation at 37°C, residual interferon levels in the mixture were estimated.
RESULTS
Induction ofIFNProduction by M. pneumoniae in Human PeripheralLymphocytes
Table 1 shows the results of experiments assessing the IFN production induced by
M. pneumoniae in the unpurified peripheral mononuclear cells and their purified
TABLE I
Induction of Interferon in Human Peripheral
Mononuclear Cells byM. pneumoniae in Individuals
IFN Titers (units/ml)"
Donors PBL T
1 279 558
2 209 508
3 488 1,097
4 200 2,650
5 210 533
aLymphocytes (5 x 105/ml) were cultured with
106 CFU/ml of M. pneumoniae at 37°C for 72
hours. Antiviral activity in the supernatants was
determined by the VSV-WISH plaque-reading
method. The values of IFN represent the means
of triplicate assays.
633T-cell fractions isolated from different healthy donors. With all individuals tested,
T-cell fractions (5 x 106/ml) produced 558 to 2,650 units/ml of IFN, when being
incubated with 106 CFU/ml of M. pneumoniae for 72 hours, although the un-
purified mononuclear cells, containing more than 70 percent of T cells, produced
lower titers of IFN than that in purified T cells. Figure 1 shows the results of IFN
production in culture fluid ofunpurified mononuclear cells, purified T cells, B cells,
and monocytes. IFN induced by 106 CFU/ml of M. pneumoniae in the T-cell frac-
tions reached a maximum in about 12 to 24 hours. Figure 1 also shows that, even
though using the optimal concentration of M. pneumoniae (106 CFU/ml), the titers
of IFN were low in B cells or negative in monocytes throughout the observation
period of three days.
The IFN production by T-cell fractions was induced by 106 to 104 CFU/ml of M.
pneumoniae, which did not affect the viability of cells after a 24-hour cultivation.
Characterization ofIFN
The types ofIFN produced byM. pneumoniae-stimulated T cells were determined
by antiserum neutralization and acid lability tests. As shown in Table 2, antiserum-
neutralizing IFNa failed to neutralize significantly the IFN produced by T cells,
under a condition that human fibroblast IFN induced by Sendai virus be completely
neutralized. In contrast, the treatment with antiserum-neutralizing IFN-y resulted in
a partial reduction of M. pneumoniae-induced but not fibroblast IFN. Treatment
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FIG. 1. Interferon titers by human
peripheral T cells, B cells, and mono-
300 cytes stimualted by M. pneumoniae.
The suspension (0.1 ml) of M. pneu-
moniae (10'CFU/ml) was added to
106 cells in 1 ml of RPMI 1640 plus
10 percent FCS. Antiviral activities in
100 each culture fluid after 72 hours' culti-
______________________________________________ ^vation were measured by the plaque
<10 reduction method of WISH-VSV in-
fection. (-0-), PBL; (-* S-),
3 6 12 24 48 72 T cells; (-A-), B cells; (-A-),
Incubation time (hr) monocyte.
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TABLE 2
Characterization of M. pneumoniae-Induced Interferon
by Antibody Neutralizationa and Low pH Stability Testb
Residual Interferon
Treatment IFN Activity (% of control)
Anti-IFNa +, Mycoplasma IFN 65
HF IFN 10
Anti-IFN-y Mycoplasma IFN 40
HF IFN 98
pH 2.0 Mycoplasma IFN 56
HF IFN 92
,Results are those from a representative experiment out of three
experiments with similar results. Mycoplasma IFN: interferon pro-
duced by T cells; HF IFN: partially purified human IFNcx induced
by Sendai virus.
bSamples were dialyzed against Sorensen's glycine-HCl buffer
[pH 2.0] for 24 hours at 4°C. The samples were returned to pH 7.4
by dialysis against phosphate-buffered saline [pH 7.4] prior assay.
with pH 2.0 also partially inactivated mycoplasma IFN but not fibroblast IFN.
Therefore by both criteria a part of the IFN induced by M. pneumoniae was IFNy.
Abrogation ofIFN Production with Horseradish Hydrogen Peroxidase
As we have recently observed that hydrogen peroxide induced IFN production by
human lymphocytes [14], we examined whether hydrogen peroxide released from M.
pneumoniae stimulated IFN production. Graded numbers (CFU/ml) of M.
pneumoniae were inoculated to 5 x 105/ml of T cells with or without 100 mcg/ml
of hydrogen peroxidase, and then IFN titers in the supernatant of cell cultures after
'72 hours' cultivation were assayed. As shown in Table 3, horseradish hydrogen
peroxidase markedly inhibited IFN production by T cells stimulated by M.
TABLE 3
Inhibition of Horseradish Peroxidase on IFN Production
by M. pneumoniae-Infected Human Peripheral Lymphocytesa
M. pneumoniae IFN Titersb
(CFU/ml) Peroxidase (units/ml)
106 990
+ 160
10'5 533
+ 37
104 560
+ 55
103 20
+ 20
'T cells (106/ml) were incubated in presence or absence of 100
mcg/ml of hydrogen peroxidase with graded number CFU of M.
pneumoniae.
bThe values of IFN represent the means of triplicate assays.
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Effects of Peroxidase Addition Times on
IFN Production Induced by M. pneumoniae
Addition Time (hours) of
Peroxidase (10 mcg/ml) IFN Titersb
After Cultivationa (units/ml)
0 40
3 50
6 39
16 101
24 209
aM. pneumoniae (105 CFU/ml) was inoculated in 0.2 ml of T-cell
suspensions (1 x 106/ml). Data represent a representative experi-
ment of three experiments with similar results.
bIFN titers in supernatants ofT cells were measured after 24 hours'
cultivation. The values represent the means of triplicate assays.
pneumoniae. In an additional experiment, 10 mcg/ml of peroxidase was added to
the cultures of mycoplasma-infected lymphocytes at intervals during cultivation.
The inhibition of IFN production by peroxidase was clearly observed when perox-
idase was added after six hours ofcultivation (Table 4). The addition ofperoxidase,
however, after 18 hours of cultivation showed only weak inhibition of IFN produc-
tion.
Next, we examined whether the hydrogen peroxide released from M. pneumoniae
directly induced IFN production by lymphocytes. One hundred milliliters of M.
pneumoniae-culture fluid (106 CFU/ml) were centrifuged at 2 x 104 g for 30
minutes, and suspended in 10 ml of RPMI 1640 tissue culture medium. After the
suspensions had been incubated at 37°C for two hours, 1 ml of the supernatant ob-
tained by centrifugation was added to 1 ml of T cells (5 x 106/ml) with or without
hydrogen peroxidase. After three days ofincubation, IFN titers in supernatants ofT
cells were assayed. As shown in Table 5, the additions ofhydrogen peroxidase to the
supernatant markedly inhibited the production of IFN; also hydrogen peroxide
(12.5 mcg/ml) in the supernatant of M. pneumoniae suspension was reduced from
10-2 mM to less then 10-4 mM measured by the colorimetric method [15].
These results suggest that IFN production by lymphocytes stimulated by M.
pneumoniae are, at least in part, due to hydrogen peroxide released from M.
pneumoniae.
TABLE 5
Abrogation of IFN Produced by T Cells Stimulated with
the Supernatants of M. pneumoniae by Peroxidasea
Concentration of Peroxidase IFN Titers (units/ml)b
(mcg/ml) (% of reduction)
25 26 (68)
12 38 (53)
6 80 (0)
- 80
aData represent a representative experiment out of three experi-
ments with similar results.
bIFN titers in supernatants of T cells (1 x 106/ml) were measured
after 72 hours' incubation at 37°C.
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DISCUSSION
There have been several reports that mycoplasmas induced IFN production by
human and animal leukocytes and by tissue-culture cells. Cole et al. reported that
some mycoplasmas, such as M. pneumoniae, M. gallisepticum, and Acholeplasma
laidlawii that produced hydrogen peroxide as a final metabolite ofglucose, induced
IFN production by ovine leukocytes [4,5,6], thoughM. orale 1 andM. synoviaealso
induce IFN production without glucose metabolites by tissue-culture cells and
leukocytes, respectively [7,4]. However, the components of each mycoplasma as
IFN inducers are not clear. In the present study we demonstrated that hydrogen
peroxide released from M. pneumoniae could induce IFN production by human
peripheral lymphocytes. The IFN was also composed, at least in part, of IFN'y.
Although IFNy was considered to be produced in T cells stimulated by specific an-
tigen, lectins [1], the production of IFN'y accompanying T-cell activation, has been
observed after oxidation of the cell surface by galactose oxidase [16,17]. This en-
zyme produces aldehydes at the cell surface which cause the cross-link with amino
groups [18], initiating the IFN production of T lymphocytes through the formation
of Schiff bases [17,19]. On the other hand, oxidative metabolites, hydrogen perox-
ide, superoxide anion, and hydroxyl radical produced cytotoxic metabolites such as
malonaldehyde in the cell membrane [20,21]. These substances were also capable of
interacting with DNA and producing mutations in cross-linking with amino groups
ofDNAthrough the formation ofSchiffbases [22,23]. These reports, that hydrogen
peroxide released from M. pneumoniae as a final metabolite ofglucose, may show a
similar effect at the surface of T cells. Ten mcg/ml of peroxidase clearly blocked
IFN induction, when added after three to six hours of cultivation, but not after 18
hours. This suggested that the contact of peroxide for certain periods was required
for induction of IFN by lymphocytes. It may be important to consider an im-
munological circuit mediated with peroxide which involves some mycoplasmas and
activated macrophages, since IFN augments the activity of natural killer cells and
regulates antibody production and cellular immunity.
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